# FDA Inspection 1197663 - Biomat USA, Inc. - February 03, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/f9d8d375-cf79-420d-96b3-52b2ea8444bf/
Source feed: FDA_Inspections

> FDA Inspection 1197663 for Biomat USA, Inc. on February 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197663
- Company Name: Biomat USA, Inc.
- Inspection Date: 2023-02-03
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1197663 - 2023-02-03](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/8a943fe7-6b90-4ec4-a409-7bc64a0e887e/)
- [FDA Inspection 1015289 - 2017-05-05](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/995a0957-705b-4858-8d21-4a9b31a6044c/)
- [FDA Inspection 837467 - 2013-06-05](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/25b70086-ad90-43b2-a2bc-457e87142579/)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/6306c138-e7e1-4209-9dd7-b5b7656cff99

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d